EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Hepatotoxicity induced by arsenic trioxide: clinical features, mechanisms, preventive and potential therapeutic strategies

Jun Wen, Aiwen Li, Ziliang Wang, Xiaoxiao Guo, Gaoling Zhang, Mark R Litzow, Qiuju Liu

Frontiers in Pharmacology · 20.02.2025 · 16

DOI: 10.3389/fphar.2025.1536388 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 20.02.2025. Verfasst von Jun Wen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, Cancer Center, The First Hospital of Jilin University, Changchun, China. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Arsenic trioxide (ATO) has shown substantial efficacy in the treatment of patients with acute promyelocytic leukemia, and the utilization of ATO as a potential treatment for other tumors is currently being investigated; thus, its clinical application is becoming more widespread. However, the toxicity of ATO has prevented many patients from receiving this highly beneficial treatment. The clinical features, mechanisms, and preventive measures for ATO hepatotoxicity, as well as potential curative strategies, are discussed in this review. This review not only discusses existing drugs for the treatment of hepatotoxicity but also focuses on potential future therapeutic agents, providing forward-looking guidance for the clinical use of small molecule extracts, trace elements, antidiabetic drugs, and vitamins.

Schlagwörter

Stichwörter der Autor:innen

acute promyelocytic leukemiaarsenic trioxidehepatotoxicitynatural small molecule extractsreactive oxygen species

Autor:innen und Institutionen

  • Department of Haematology, Cancer Center, The First Hospital of Jilin University, Changchun, China.
  • Center of Hematology, Peking University People's Hospital Qingdao, Qingdao, China.
  • Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, United States.

Zitieren

APA

Wen, J., Li, A., Wang, Z., Guo, X., Zhang, G., Litzow, M. R., & Liu, Q. (2025). Hepatotoxicity induced by arsenic trioxide: clinical features, mechanisms, preventive and potential therapeutic strategies. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1536388

Vancouver

Wen J, Li A, Wang Z, Guo X, Zhang G, Litzow MR, et al. Hepatotoxicity induced by arsenic trioxide: clinical features, mechanisms, preventive and potential therapeutic strategies. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1536388

BibTeX
@article{Wen2025,
  author = {Wen, Jun and Li, Aiwen and Wang, Ziliang and Guo, Xiaoxiao and Zhang, Gaoling and Litzow, Mark R and Liu, Qiuju},
  title = {Hepatotoxicity induced by arsenic trioxide: clinical features, mechanisms, preventive and potential therapeutic strategies},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1536388}
}
Kostenlos starten →